Literature DB >> 11912252

C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys.

Masaomi Nangaku1, Jeffrey Pippin1, William G Couser1.   

Abstract

Although it was once considered only a marker of glomerular damage, accumulating evidence indicates that proteinuria per se is nephrotoxic and contributes to the progression of renal injury. Several studies have demonstrated that activation of complement in proteinuric urine results in tubular and interstitial damage. It was previously demonstrated that acute complement-mediated interstitial disease is induced by C5b-9. Here the role of C5b-9 in the progression of chronic proteinuric renal disease was investigated in a nonimmunologic remnant kidney model. Five-sixths nephrectomies were performed for normocomplementemic control and C6-deficient PVG rats. Tubulointerstitial injury was assessed by measurement of two independent markers of tubular injury (i.e., vimentin and osteopontin), interstitial accumulation of the extracellular matrix components collagen type I, collagen type IV, and laminin, interstitial macrophage infiltration, and renal function. The two groups developed similar levels of proteinuria and BP. Whereas C3 deposition on the brush border was equivalent for rats in the two groups, C5b-9 deposition was observed only for normocomplementemic rats. At day 35, the degrees of both tubulointerstitial injury and renal failure were the same for the two groups. Tubulointerstitial injury in normocomplementemic rats was still severe at day 70. In contrast, interstitial injury in C6-deficient rats had improved markedly at day 70, with improvements in renal function. In a rat model of chronic progressive renal disease secondary to nephron loss, the initial interstitial changes are complement-independent and largely reversible, whereas progressive interstitial fibrosis is mediated predominantly by C5b-9. Treatment to reduce C5b-9 attack in tubular cells may slow progression and facilitate recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912252     DOI: 10.1681/ASN.V134928

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Leaked protein and interstitial damage in the kidney: is complement the missing link?

Authors:  N S Sheerin; S H Sacks
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 2.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

3.  Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.

Authors:  Takayoshi Miura; Shin Goto; Seitaro Iguchi; Hisaki Shimada; Mitsuhiro Ueno; Shin-ichi Nishi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

4.  Effects of low protein intake on the development of the remaining kidney in subtotally nephrectomized immature rats: expression of inducible and endothelial NO synthase.

Authors:  Masaki Mino; Hideshi Ihara; Shunji Kozaki; Tomohiro Kondo; Ai Takeshita; Ken Takeshi Kusakabe; Toshiya Okada
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

5.  C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.

Authors:  Gopala K Rangan
Journal:  World J Nephrol       Date:  2016-05-06

6.  High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population.

Authors:  Aki Ashitani; Toshinori Ueno; Ayumu Nakashima; Shigehiro Doi; Kiminori Yamane; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2017-12-26       Impact factor: 2.801

7.  Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.

Authors:  Yuri Ozawa; Hiroyuki Kobori
Journal:  Am J Physiol Renal Physiol       Date:  2007-04-04

8.  Expression of complement components differs between kidney allografts from living and deceased donors.

Authors:  Maarten Naesens; Li Li; Lihua Ying; Poonam Sansanwal; Tara K Sigdel; Szu-Chuan Hsieh; Neeraja Kambham; Evelyne Lerut; Oscar Salvatierra; Atul J Butte; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

Review 9.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

10.  Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.

Authors:  Mauro Abbate; Carla Zoja; Daniela Corna; Daniela Rottoli; Cristina Zanchi; Nadia Azzollini; Susanna Tomasoni; Silvia Berlingeri; Marina Noris; Marina Morigi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.